Lyso-GL-3: An important Fabry biomarker associated with adverse clinical outcomesPublications , Diagnostics April 1, 2021
Biomarkers in Rare Diseases play a dual and significant role in supporting improved clinical outcomes. In Fabry Disease (FD), the glycosphingolipid globotriaosylceramide (Gb3/GL-3) and its… Read more
Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotesARCHIMEDlife News , Publications October 19, 2016Background: Fabry disease (FD) is a rare X-linked lysosomal storage disorder due to mutations in the a-galactosidase A gene (GLA) that result in absent or markedly… Read more
Loading more posts ...